Whole-Body Imaging Market

Whole-Body Imaging: Market Overview

The global whole-body imaging market size is expected to be valued at US$ 17.4 Billion in 2022 and US$ 20.8 Billion in 2032. It is anticipated to showcase steady growth by exhibiting a CAGR of 6.3% in the forecast period from 2022 to 2032. The increasing aging demographics and the urgent need to diagnose chronic diseases are estimated to propel the sales of whole-body imaging systems in future.

Whole-body imaging refers to Magnetic Resonance Imaging (MRI) or full-body CT scan in the healthcare sector. It is considered to be an effective and quick modality to detect a particular disease in an individual’s body.

These imaging systems are capable of broadening the scope of vision in terms of the biological function of the body. These also help in tracking the immune system’s cellular activities in real-time.

These can enhance the ability of healthcare professionals to detect a metastatic spread, carotid, as well as peripheral vascular disease. These utilize computed tomography to generate elaborate, cross-sectional, and thin X-ray images. These images further allow doctors to examine a particular area of the patient’s body, such as the lungs or heart.

The rapid improvement in PET and CT scans is expected to boost the development of accurate and safe procedures that can be used in emergency cases. The introduction of portable devices, surging dependency on computing power, and enhancements in detector systems are likely to propel the market. In addition to this, the miniaturization of electronics is anticipated to spur the sales of whole-body imaging systems.

Which are Some of the Trends Aiding the Growth in Whole-Body Imaging Market?

The high demand for advanced imaging modalities from universities and teaching hospitals to deliver training for latest technologies is a vital factor that is estimated to fuel the whole-body imaging market growth. The increasing usage of medical imaging in the field of digital healthcare is another factor that is anticipated to bode well for the market.

The presence of favorable regulatory scenarios for imaging modalities in developed countries is set to augment superior patient management. The rising usage of nuclear imaging techniques to effectively diagnose thyroid disease, cancer, heart conditions, and gall bladder disease is also likely to propel the market.

What are the Challenges Faced by the Whole-Body Imaging Industry?

Whole-body imaging systems are very expensive owing to the integration of state-of-the-art technologies. These often involve blood testing, CT scan, stress test, MRI scan, and cardiac screening. This type of testing can also lead to too many false positives. In such cases, the patient needs to go through more invasive testing which very often turns out to be normal. Invasive tests require high cost spending, which may negatively affect the demand for whole-body imaging systems in the near future.

Why is North America Emerging as an Opportunistic Whole-Body Imaging Market?

North America is projected to generate the largest whole-body imaging market share in the evaluation period. This growth is attributable to the presence of a large number of prominent players in Canada and the U.S.

Besides, the ongoing development of cutting-edge imaging systems for providing better healthcare to patients is set to accelerate the market. In March 2022, for instance, Canada-based Intelerad Medical System introduced its new Enterprise Imaging and Informatics Suite. It would deliver an industry-leading enterprise imaging solution to health systems and hospitals. Thus, the rising number of new product launches is expected to augur well for the North America market.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Asia Pacific Contributing to Growth of the Whole-Body Imaging Market?

Asia Pacific is estimated to remain in the second position, followed by North America in the assessment period. The high demand for technologically advanced diagnostic systems is a crucial factor that is set to drive the market.

The increasing prevalence of chronic diseases in emerging economies, such as India and China is also anticipated to push the Asia Pacific whole-body imaging market size. According to researchers at the National Institute of Cancer Prevention and Research (NICPR), around 2.25 million people are estimated to live with cancer in India. In 2018, the usage of tobacco accounted for nearly 3,17,928 deaths in both men and women in this country. These numbers are set to surge in future, thereby propelling the Asia Pacific market.

Market Competition

Some of the renowned companies operating in the whole-body imaging market are Mediso Ltd., MinFound Medical Systems Co., Ltd., Pure Imaging Phantoms, General Electric Company, NeuroLogica Corp., MiE GmbH, and Koninklijke Philips N.V. among others.

Majority of the key players are aiming to develop multimodal imaging devices for the purpose of preclinical research activities. They are also striving to come up with novel technologies by investing huge sums in R&D. Some of the other companies are entering in collaborations with local firms to speed up the development of affordable and sophisticated imaging systems.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sign-Up

Report Scope

Key Segments Profiled in the Whole-Body Imaging Market

By Product Type:

• Positron Emission Tomography Scan
• Computed Tomography Scan

By Application:

• Specialty Clinics
• Diagnostic Centers
• Hospitals

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• Middle East and Africa